BrightInsight Adds Xealth, Woebot Health and Claritas Rx to the BrightInsight EcosystemCompanies Will Collaborate to Drive Digital Innovation, Adoption and Engagement BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated...
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections — NDA resubmission expected in Second Half of 2024, if successful– –Oral sulopenem, if approved, could be the first...
Deciphera Pharmaceuticals, Inc. Announces Publication of INTRIGUE Phase 3 Clinical Study Results in Journal of Clinical Oncology – Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients...
Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease This press release was updated on July 28, 2022 to reflect that Cleerly...
Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101 Findings from First-in-Human Study Support Continued Clinical Development of Investigational IOP-lowering Therapy; New...
Kit Check Recognized as Industry-Leading Vendor for Kit and Tray Management. 65% of participants consider Kit Check to be the top industry leader Washington, D.C. – (June 10, 2022) – Kit Check, the leading automation vendor in Medication Intelligence™, was recently...
Recent Comments